Whitehawk Therapeutics (WHWK) Operating Expenses (2013 - 2026)
Whitehawk Therapeutics (WHWK) reported Operating Expenses of $23.5 million for Q1 2026, up 5.18% year-over-year from $22.4 million in Q1 2025, and down 5.48% on a QoQ basis from $24.9 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 14 years of Operating Expenses data on file, last reported at $23.5 million in Q1 2026.
- Quarterly Operating Expenses rose 5.18% year-over-year to $23.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $122.7 million (up 34.93% YoY) and the FY2025 annual result came in at $121.5 million, up 30.08% from the prior year.
- Operating Expenses eased to $23.5 million in Q1 2026 per WHWK's latest filing, from $24.9 million in the prior quarter.
- Across five years, Operating Expenses topped out at $54.7 million in Q2 2025 and bottomed at $16.1 million in Q1 2022.
- The 5-year median for Operating Expenses is $22.7 million (2023), against an average of $24.3 million.
- Peak annual rise in Operating Expenses reached 462.5% in 2022, while the deepest fall reached 77.92% in 2022.
- Tracing WHWK's Operating Expenses over 5 years: stood at $20.7 million in 2022, then grew by 16.14% to $24.0 million in 2023, then rose by 8.94% to $26.2 million in 2024, then slipped by 4.97% to $24.9 million in 2025, then slipped by 5.48% to $23.5 million in 2026.
- Per Business Quant, the three latest WHWK Operating Expenses figures stand at $23.5 million (Q1 2026), $24.9 million (Q4 2025), and $19.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.33 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -138.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.85 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 898.54 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | 23.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.52 Mn |
| Dec 31, 2025 | 24.89 Mn |
| Sep 30, 2025 | 19.55 Mn |
| Jun 30, 2025 | 54.75 Mn |
| Mar 31, 2025 | 22.36 Mn |
| Dec 31, 2024 | 26.19 Mn |
| Sep 30, 2024 | 20.63 Mn |
| Jun 30, 2024 | 21.76 Mn |
| Mar 31, 2024 | 24.87 Mn |
| Dec 31, 2023 | 24.04 Mn |
| Sep 30, 2023 | 23.81 Mn |
| Jun 30, 2023 | 25.75 Mn |
| Mar 31, 2023 | 22.69 Mn |
| Dec 31, 2022 | 20.70 Mn |
| Sep 30, 2022 | 19.28 Mn |
| Jun 30, 2022 | 21.80 Mn |
| Mar 31, 2022 | 16.12 Mn |
| Dec 31, 2021 | 16.95 Mn |
| Sep 30, 2021 | 87.31 Mn |
| Jun 30, 2021 | 3.88 Mn |
| Mar 31, 2021 | 4.21 Mn |
| Dec 31, 2020 | 5.75 Mn |
| Sep 30, 2020 | 2.89 Mn |
| Jun 30, 2020 | 5.74 Mn |
| Mar 31, 2020 | 4.11 Mn |
| Dec 31, 2019 | 4.66 Mn |
| Sep 30, 2019 | 4.97 Mn |
| Jun 30, 2019 | 5.98 Mn |
| Mar 31, 2019 | 8.84 Mn |
| Dec 31, 2018 | 8.87 Mn |
| Sep 30, 2018 | 7.62 Mn |
| Jun 30, 2018 | 7.37 Mn |
| Mar 31, 2018 | 7.48 Mn |
| Dec 31, 2017 | 6.29 Mn |
| Sep 30, 2017 | 4.76 Mn |
| Jun 30, 2017 | 5.58 Mn |
| Mar 31, 2017 | 4.76 Mn |
| Dec 31, 2016 | 3.31 Mn |
| Sep 30, 2016 | 4.75 Mn |
| Jun 30, 2016 | 4.38 Mn |
| Mar 31, 2016 | 4.21 Mn |
| Dec 31, 2015 | 9,613.00 |
| Sep 30, 2015 | 4,328.00 |
| Jun 30, 2015 | 5,103.00 |
| Mar 31, 2015 | 3,962.00 |
| Dec 31, 2014 | 9,762.00 |
| Sep 30, 2014 | 4,765.00 |
| Jun 30, 2014 | 5,307.00 |
| Mar 31, 2014 | 4,138.00 |
| Dec 31, 2013 | 8,087.00 |
| Sep 30, 2013 | 4,475.00 |
| Jun 30, 2013 | 5,456.00 |